NOX 2.86% 7.2¢ noxopharm limited

Ann: Veyonda FDA Approved Trial to Commence, page-33

  1. 917 Posts.
    lightbulb Created with Sketch. 129
    Prognosis for metastatic sarcoma is absymal. Any improvement in this even by a few months is a big deal and will be quickly endorsed by FDA. A very strategic decision, kudos to Nox.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.